These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36849408)

  • 21. Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2.
    Kong Y; Wu R; Zhang S; Zhao M; Wu H; Lu Q; Fu S; Su Y
    Int Immunopharmacol; 2020 Nov; 88():106918. PubMed ID: 32866786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGR2-mediated regulation of m
    Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
    Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.
    Wang K; Wang G; Li G; Zhang W; Wang Y; Lin X; Han C; Chen H; Shi L; Reheman A; Li J; Li Z; Yang X
    Apoptosis; 2023 Apr; 28(3-4):627-638. PubMed ID: 36719469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
    Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
    Zhang X; Cai X
    Medicine (Baltimore); 2022 Nov; 101(45):e31195. PubMed ID: 36397411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WTAP facilitates progression of endometrial cancer via CAV-1/NF-κB axis.
    Li Q; Wang C; Dong W; Su Y; Ma Z
    Cell Biol Int; 2021 Jun; 45(6):1269-1277. PubMed ID: 33559954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.
    Wang LJ; Xue Y; Li H; Huo R; Yan Z; Wang J; Xu H; Wang J; Cao Y; Zhao JZ
    J Cell Mol Med; 2020 May; 24(9):4981-4991. PubMed ID: 32281240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
    Han X; Liu J; Cheng G; Cui S
    Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA.
    Ding L; Wang R; Zheng Q; Shen D; Wang H; Lu Z; Luo W; Xie H; Ren L; Jiang M; Yu C; Zhou Z; Lin Y; Lu H; Xue D; Su W; Xia L; Neuhaus J; Cheng S; Li G
    J Exp Clin Cancer Res; 2022 Jun; 41(1):187. PubMed ID: 35650605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models.
    Ge Y; Chen R; Ling T; Liu B; Huang J; Cheng Y; Lin Y; Chen H; Xie X; Xia G; Luo G; Yuan S; Xu A
    J Clin Invest; 2024 May; 134(14):. PubMed ID: 39007267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WTAP-mediated m
    You Y; Liu J; Zhang L; Li X; Sun Z; Dai Z; Ma J; Jiao G; Chen Y
    Cell Death Dis; 2023 Jan; 14(1):33. PubMed ID: 36650131
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
    Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N6-methyladenosine writer WTAP contributes to the induction of immune tolerance post kidney transplantation by targeting regulatory T cells.
    Wang Z; Qi Y; Feng Y; Xu H; Wang J; Zhang L; Zhang J; Hou X; Feng G; Shang W
    Lab Invest; 2022 Nov; 102(11):1268-1279. PubMed ID: 35864150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WTAP-mediated N6-methyladenosine modification on EGR3 in different types of epithelial ovarian cancer.
    Fu Y; Jia XC
    J Biol Regul Homeost Agents; 2020; 34(4):1505-1512. PubMed ID: 32893607
    [No Abstract]   [Full Text] [Related]  

  • 39. The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics.
    Ju G; Lei J; Cai S; Liu S; Yin X; Peng C
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m
    Wang J; Zhang J; Ma Y; Zeng Y; Lu C; Yang F; Jiang N; Zhang X; Wang Y; Xu Y; Hou H; Jiang S; Zhuang S
    Aging (Albany NY); 2021 Mar; 13(8):11135-11149. PubMed ID: 33819187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.